STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and moreWorldPing
Image via STAT.

What happened

A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall following trial setbacks…

Key facts

  • A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall following trial setbacks…
  • Reported by STAT and published Thu, 10 Sep 2026 13:09:22 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. Opinion: John Fetterman’s post-stroke, politically problematic behaviors offer lessons about brain health on Capitol Hill

  2. STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Related WorldPing coverage

The 2026 Proms: tell us about your favourite concertsWorldPing
The Guardian

The 2026 Proms: tell us about your favourite concerts

Ahead of Saturday’s Last Night, we want to hear what you’ve enjoyed this year. Has any of the new music made it on to your playlists? Which soloists wowed you? Did you sing along to Hey Jude with the Jupiter Ensemble ?

Brief by WorldPing · Original reporting by The Guardian